Ford’s new vehicle sales slow in August, in line with expectations

Ford’s new vehicle sales slow in August, in line with expectations


2023 Ford F-150 Raptor R

Ford

DETROIT – Ford Motor on Friday said its U.S. sales last month increased double-digits from a year earlier but were off about 4% from the prior month, as the company and auto industry continue to manage significant supply chain issues.

The Detroit automaker reported August sales of 158,088 new vehicles in the U.S., a 27% increase from August 2021, when the company’s production and sales were significantly impacted by a shortage of semiconductor chips. Last month’s sales were down 3.6% compared to July, including an 8% decline in its F-Series pickup trucks.

Those sales were in line with analyst expectations, though. The company said its Ford brand was America’s best-selling brand for a second consecutive month.

Sales of Ford’s profitable F-Series pickups were up 1.7% for the month from August 2021 but off 10.7% for the first eight months of the year compared with the same period last year. The company has sold 6,842 models of its all-electric F-150 Lightning pickup as of Aug. 31, including 2,373 vehicles last month.

“F-Series was America’s best-selling truck, best-selling hybrid truck and best-selling electric truck with F-150 Lightning in August. Ford’s overall electric vehicle portfolio expanded four–fold in July, while conquesting from competitors at a rate over 60%,” Andrew Frick, Ford vice president of sales, distribution and trucks, said in a release.

Ford’s 2022 electric vehicle sales totaled more than 36,500 units through August. That included sales of about 5,900 vehicles in August, which was 23% lower than the prior month but up more than 300% from a year ago.

Year-to-date sales of all Ford’s vehicles, including its luxury Lincoln brand, totaled more than 1.2 million units through August, a 0.2% decrease from a year ago. At the end of last month, the automaker’s U.S. vehicle inventory, including dealer stock and in-transit vehicle, was about 259,000 units, up from 245,000 in July.

J.D. Power and LMC Automotive estimate total U.S. new vehicle sales last month topped 980,000 units, which would be 2.6% lower than August 2021 – the first month the auto industry’s vehicle inventories were significantly impacted by an ongoing shortage of semiconductor chips.

RBC Capital Markets said the seasonally adjusted annualized rate, or SAAR, for new vehicles was 13.4 million, slightly higher than its 13.2 million forecast and in line with July’s 13.5 million. The SAAR is a closely watched metric by analysts and investors.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More